Systematic review and meta‐analysis of skin substitutes in the treatment of diabetic foot ulcers: Highlights of a Cochrane systematic review
Open Access
- 6 April 2016
- journal article
- review article
- Published by Wiley in Wound Repair and Regeneration
- Vol. 24 (4) , 737-744
Abstract
Skin substitutes are increasingly used in the treatment of various types of acute and chronic wounds. The aim of this study was to perform a systematic review and meta‐analysis to evaluate the effectiveness of skin substitutes on ulcer healing and limb salvage in the treatment of diabetic foot ulcers. Randomized clinical trials were searched and assessed following the methodology of The Cochrane Collaboration. We included 17 trials, totaling 1655 randomized participants. Risk of bias was variable among included trials. Thirteen trials compared the skin substitutes with standard care. The pooled results showed that that skin substitutes can, in addition to standard care, increase the likelihood of achieving complete ulcer closure compared with standard care alone after 6–16 weeks (risk ratio 1.55, 95% confidence interval [CI] 1.30–1.85). Four of the included trials compared two types of skin substitutes but no particular product showed a superior effect over another. Two trials reported on total incidence of lower limb amputations. Pooling the results of these two trials yielded a statistically significantly lower amputation rate among patients treated with skin substitutes (risk ratio 0.43, 95% CI 0.23–0.81), although the absolute risk difference was small (−0.06, 95% CI −0.10 to −0.01). This systematic review provides evidence that skin substitutes can, in addition to standard care, increase the likelihood of achieving complete ulcer closure compared with standard care alone in the treatment of diabetic foot ulcers. However, effectiveness on the long term, including lower limb salvage and recurrence, is currently lacking and cost‐effectiveness is unclear.Keywords
This publication has 24 references indexed in Scilit:
- A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcersInternational Wound Journal, 2013
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Two-Step Autologous Grafting Using HYAFF Scaffolds in Treating Difficult Diabetic Foot Ulcers: Results of A Multicenter, Randomized Controlled Clinical Trial With Long-Term Follow-upThe International Journal of Lower Extremity Wounds, 2011
- Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre studyInternational Wound Journal, 2009
- Apligraf in the Treatment of Neuropathic Diabetic Foot UlcersThe International Journal of Lower Extremity Wounds, 2009
- Practical guidelines on the management and prevention of the diabetic footDiabetes/Metabolism Research and Reviews, 2008
- The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16‐week pilot studyInternational Wound Journal, 2006
- Healing diabetic neuropathic foot ulcers: are we getting better?Diabetic Medicine, 2004
- Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatmentsDiabetes & Metabolism, 2004
- Use of Dermagraft, a Cultured Human Dermis, to Treat Diabetic Foot UlcersDiabetes Care, 1996